pantothenic acid has been researched along with Cognition Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guzeva, OV; Guzeva, VI; Guzeva, VV; Okhrim, IV; Zgoda, VN | 1 |
| Nikitina, YM; Smulevich, AB; Ternovaya, ES; Volel, BA | 1 |
| Kamchatov, PR; Mikhaĭlova, NA | 1 |
| Watanabe, R | 1 |
2 trial(s) available for pantothenic acid and Cognition Disorders
| Article | Year |
|---|---|
[Diagnosis and correction of cognitive impairment in preschool age children with epilepsy].
Topics: Child; Child, Preschool; Cognition Disorders; Electroencephalography; Epilepsy; Female; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Pantothenic Acid | 2015 |
[Pantogam activ (D-, L-hopantenic acid) in the treatment of cognitive and anxiety disorders in patients with arterial hypertension].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Anxiety Disorders; Blood Pressure Monitoring, Ambulatory; Cognition Disorders; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Hypertension; Male; Middle Aged; Nootropic Agents; Pantothenic Acid; Psychometrics; Treatment Outcome; Young Adult | 2015 |
2 other study(ies) available for pantothenic acid and Cognition Disorders
| Article | Year |
|---|---|
[The use of pantogam in patients with moderate cognitive disorders of vascular genesis].
Topics: Aged; Cerebrovascular Disorders; Cognition Disorders; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Nootropic Agents; Pantothenic Acid; Treatment Outcome | 2009 |
[Consciousness disorders in the aged due to therapeutic drugs].
Topics: Aged; Anemia; Cognition Disorders; Consciousness Disorders; Drug Interactions; Flunarizine; gamma-Aminobutyric Acid; Humans; Intestinal Absorption; Pantothenic Acid; Parasympatholytics; Parkinson Disease, Secondary; Psychotropic Drugs; Reye Syndrome | 1990 |